Registered record
Number: 07725451
Type: ltd
SIC: 61900, 62090
Register statusactive
Incorporated2 August 2011
Accounts due29 December 2026
Confirmation due9 December 2026
Record retrieved via live Companies House proxy on 19 October 2026. Proxy responses may be cached; use the official register for a time-critical check. This is a public-record research page, not a credit score, investment conclusion or tax determination.
Identity and review status
1 mapped fund association
Association means the company appeared in the dated portfolio research corpus. It does not prove a fund's current holding or SEIS/EIS eligibility.
Global Legal Entity Identifier
LEI: 213800RKLMVGUGR83636
GLEIF legal name: HUMA THERAPEUTICS LIMITED
Registration status: ISSUED
Next renewal: 17 July 2027
The link uses the exact Companies House registration number in GLEIF. A lapsed LEI is an identifier-renewal state, not a solvency conclusion.
Verify at GLEIF →Observed names
Identity and alias evidence
Names are not merged by similarity. Every non-current label below is tied to this exact company number or to the exact GLEIF identifier join, and its role is stated.
| Name as published | Evidence type | Observation or match |
|---|---|---|
| HUMA THERAPEUTICS LIMITED | Current registered name | Companies House number 07725451 |
| HUMAFORHEALTH LIMITED | Previous registered name | Effective 16 April 2020 · ceased 17 April 2020 |
| MEDOPAD LTD | Previous registered name | Effective 2 August 2011 · ceased 16 April 2020 |
Exact links only
Company relationship map
This graph shows exact company-number and legal-identifier links. It does not infer beneficial ownership, control or group structure from names.
CompanyHUMA THERAPEUTICS LIMITED
07725451Observed facts
Cross-source evidence timeline
Dated company filings, public-contract notices and identifier events are sorted together. This is chronology, not a claim that one event caused another.
- Officers dated 25 September 2026Companies House filing · CH01 · Officers
- LEI record updatedGLEIF · ISSUED · FULLY_CORROBORATED
- Confirmation Statement made up to 25 November 2025Companies House filing · CS01 · Confirmation Statement
- Persons With Significant Control dated 25 November 2025Companies House filing · PSC04 · Persons With Significant Control
- Accounts made up to 31 December 2024Companies House filing · AA · Accounts
- Persons With Significant Control dated 23 July 2025Companies House filing · PSC04 · Persons With Significant Control
- CapitalCompanies House filing · SH01 · Capital
- Accounts made up to 31 December 2023Companies House filing · AA · Accounts
- CapitalCompanies House filing · SH01 · Capital
- MortgageCompanies House filing · MR04 · Mortgage
- Accounts made up to 30 December 2023Companies House filing · AA01 · Accounts
- Confirmation Statement made up to 25 November 2024Companies House filing · CS01 · Confirmation Statement
- CapitalCompanies House filing · SH01 · Capital
- Accounts made up to 31 December 2023Companies House filing · AA01 · Accounts
- Registered name ceased: HUMAFORHEALTH LIMITEDCompanies House · Previous-name record
- Registered name became HUMAFORHEALTH LIMITEDCompanies House · Previous-name record
- Registered name ceased: MEDOPAD LTDCompanies House · Previous-name record
- LEI registration first recordedGLEIF · 213800RKLMVGUGR83636
- Company incorporatedCompanies House · Registered as HUMA THERAPEUTICS LIMITED
- Registered name became MEDOPAD LTDCompanies House · Previous-name record
Companies House
Open complete official history →Filing timeline
Recent events are shown newest first. Filing codes and dates come directly from Companies House; descriptions are concise labels, not legal interpretations.
- Officers dated 25 September 2026
CH01· Officers - Confirmation Statement made up to 25 November 2025
CS01· Confirmation Statement - Persons With Significant Control dated 25 November 2025
PSC04· Persons With Significant Control - Accounts made up to 31 December 2024
AA· Accounts - Persons With Significant Control dated 23 July 2025
PSC04· Persons With Significant Control - Capital
SH01· Capital - Capital
SH01· Capital - Accounts made up to 31 December 2023
AA· Accounts - Capital
SH01· Capital - Capital
SH01· Capital - Mortgage
MR04· Mortgage - Accounts made up to 30 December 2023
AA01· Accounts - Confirmation Statement made up to 25 November 2024
CS01· Confirmation Statement - Capital
SH01· Capital - Capital
SH01· Capital - Accounts made up to 31 December 2023
AA01· Accounts
Ownership and governance sources
CompanyBeacon does not republish raw officer, PSC, address or date-of-birth records. For ownership or governance diligence, review the current official registers and record the source date separately from any conclusion.
People with significant control
PSC entries describe published legal control and are not necessarily a complete economic ownership graph.
Review the official PSC register →Company officers
Appointment records are governance evidence, not proof of beneficial ownership, conduct or current decision-making authority.
Review the official officer list →No parent relationship reported
DIRECT_ACCOUNTING_CONSOLIDATION_PARENT: NON_CONSOLIDATING
ULTIMATE_ACCOUNTING_CONSOLIDATION_PARENT: NON_CONSOLIDATING
An exception explains LEI reporting, not the absence of ownership or control.
Source dates and limitations
- charity-commission-register: extract Not available, imported 25 July 2026.
- companies-house-relevant-subset: extract Not available, imported 25 July 2026.
- contracts-finder-daily-csv: extract 18 October 2026, imported 19 October 2026.
- GLEIF LEI2: exact Companies House-number projection from R2 snapshot 11 August 2026; official API checked 19 October 2026. CC0 1.0.
- GLEIF relationship reporting: exact LEI projection snapshot 24 August 2026, generated 25 August 2026.
- Live company status and filing metadata can change after this page is cached. Companies House remains authoritative.
- Raw officer, PSC, address and date-of-birth records are not republished.
- SEIS/EIS qualification, investment performance, creditworthiness and beneficial ownership are not inferred.